Integrative mRNA profiling comparing cultured primary cells with clinical samples reveals PLK1 and C20orf20 as therapeutic targets in cutaneous squamous cell carcinoma

C20orf20 (MRG-binding protein) as a potential therapeutic target for colorectal cancer

(2010) K Yamaguchi et al.   BRITISH JOURNAL OF CANCER

Polo-like Kinase 1 (Plk1) as a Novel Drug Target in Chronic Myeloid Leukemia: Overriding Imatinib Resistance with the Plk1 Inhibitor BI 2536

(2010) K. V. Gleixner et al.   CANCER RESEARCH

Polo-like kinase 1 (Plk1) in non-melanoma skin cancers

(2010) Travis Schmit et al.   CELL CYCLE

Molecular Mechanisms of Cardiovascular Toxicity of Targeted Cancer Therapeutics

(2010) Hui Cheng et al.   CIRCULATION RESEARCH

Targeting Polo-like Kinase in Cancer Therapy

(2010) Y. Degenhardt et al.   CLINICAL CANCER RESEARCH

Gene expression profiling in head and neck squamous cell carcinoma

(2010) Boudewijn JM Braakhuis et al.   Current Opinion in Otolaryngology & Head and Neck Surgery

Activation of PPARβ/δ Causes a Psoriasis-Like Skin Disease In Vivo

(2010) Malgorzata Romanowska et al.   PLoS One

Systematic comparison of nonmelanoma skin cancer microarray datasets reveals lack of consensus genes

(2009) R. Van Haren et al.   BRITISH JOURNAL OF DERMATOLOGY

Single Nucleotide Polymorphism Array Analysis Defines a Specific Genetic Fingerprint for Well-Differentiated Cutaneous SCCs

(2009) Karin J. Purdie et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Targeted Depletion of Polo-Like Kinase (Plk) 1 Through Lentiviral shRNA or a Small-Molecule Inhibitor Causes Mitotic Catastrophe and Induction of Apoptosis in Human Melanoma Cells

(2009) Travis L. Schmit et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Inhibition of Poly(ADP-Ribose) Polymerase in Tumors fromBRCAMutation Carriers

(2009) Peter C. Fong et al.   NEW ENGLAND JOURNAL OF MEDICINE

Polo-Like Kinase (PLK) Inhibitors in Preclinical and Early Clinical Development in Oncology

(2009) P. Schoffski   ONCOLOGIST

The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis

(2008) Adam I Riker et al.   BMC Medical Genomics

Identification of copy number gain and overexpressed genes on chromosome arm 20q by an integrative genomic approach in cervical cancer: Potential role in progression

(2008) Luigi Scotto et al.   GENES CHROMOSOMES & CANCER

Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression

(2008) B Carvalho et al.   GUT

Epidermolysis bullosa and the risk of life-threatening cancers: The National EB Registry experience, 1986-2006

(2008) Jo-David Fine et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY